187 results  1 of 10 

1 Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
Blood Res.2023;58(S1):S109-S113.   Published online 2023 April 30     DOI: http://dx.doi.org/10.5045/br.2023.2023054
      
2 Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia
Cheonghwa Lee, Ha Nui Kim, Jung Ah Kwon, Soo-Young Yoon, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Jung Yoon
Ann Lab Med.2023;43(5):503-507.   Published online 2023 April 21     DOI: http://dx.doi.org/10.3343/alm.2023.43.5.503
      
3 Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Jae Joon Han
Blood Res.2023;58(S1):S58-S65.   Published online 2023 April 7     DOI: http://dx.doi.org/10.5045/br.2023.2023035
      
4 Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Eun-Ji Choi
Blood Res.2023;58(S1):S29-S36.   Published online 2023 March 9     DOI: http://dx.doi.org/10.5045/br.2023.2023017
      
5 Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia
Seon Young Kim, Hee Jin Huh
Ann Lab Med.2023;43(4):323-324.   Published online 2023 February 24     DOI: http://dx.doi.org/10.3343/alm.2023.43.4.323
      
6 Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
Jin Ju Kim, Ji Eun Jang, Hyeon Ah Lee, Mi Ri Park, Hye Won Kook, Seung-Tae Lee, Jong Rak Choi, Yoo Hong Min, Saeam Shin, June-Won Cheong
Ann Lab Med.2023;43(4):328-336.   Published online 2023 February 24     DOI: http://dx.doi.org/10.3343/alm.2023.43.4.328
      
7 The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review
Reham Osama Mansour, Shaimaa El-Ashwah, May Denewer
Blood Res.2023;58(1):13-19.   Published online 2023 February 8     DOI: http://dx.doi.org/10.5045/br.2023.2022144
      
8 Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia
Seo-Yeon Ahn, TaeHyung Kim, Mihee Kim, Ga-Young Song, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Chul Won Jung, Jun-Ho Jang, Hee Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung-Hyun Kim, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim
Cancer Res Treat.2023;55(3):1011-1022.   Published online 2023 January 26     DOI: http://dx.doi.org/10.4143/crt.2022.1407
      
9 Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1
Sang Mee Hwang, Beom Joon Kim, Jee-Soo Lee, Moon-Woo Seong, Soo Hyun Seo, Jin Ho Paik, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Yoon Hwan Chang, Soo Mee Bang
Ann Lab Med.2022;42(6):678-682.   Published online 2022 November 1     DOI: http://dx.doi.org/10.3343/alm.2022.42.6.678
      
10 Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
Young Eun Lee, Ha Jin Lim, Ju Heon Park, Hye Ran Kim, Min-Gu Kang, Young Kuk Cho, Jong Hee Shin, Myung Geun Shin
Ann Lab Med.2022;42(5):585-589.   Published online 2022 September 1     DOI: http://dx.doi.org/10.3343/alm.2022.42.5.585
      
11 Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation
Jikyo Lee, Sung Min Kim, Soonok Kim, Jiwon Yun, Dajeong Jeong, Young Eun Lee, Eun-Youn Roh, Dong Soon Lee
Ann Lab Med.2022;42(5):590-596.   Published online 2022 September 1     DOI: http://dx.doi.org/10.3343/alm.2022.42.5.590
      
12 골수형성이상증후군/급성골수성백혈병 환자에서 발견된 DDX41의 새로운 생식세포 돌연변이
Min-Sun Kwak, In Hwa Jeong, Sung-Hyun Kim, Namhee Kim
Lab Med Online.2022;12(3):209-213.   Published online 2022 July 1     DOI: http://dx.doi.org/10.47429/lmo.2022.12.3.209
      
13 Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, Inho Kim, June-Won Cheong, Won Sik Lee, Byung Soo Kim, Deog-Yeon Jo, Chul Won Jung, Chu Myoung Seong, Jae Hoon Lee, Young Jin Yuh, Min Kyoung Kim, Hun-Mo Ryoo, Moo-Rim Park, Su-Hee Cho, Hoon-Gu Kim, Dae Young Zang, Jinny Park, Hawk Kim, Seryeon Lee, Sung-Hyun Kim, Myung Hee Chang, Ho Sup Lee, Chul Won Choi, Jihyun Kwon, Sung-Nam Lim, Suk-Joong Oh, Inkyung Joo, Dong-Wook Kim
Blood Res.2022;57(2):144-151.   Published online 2022 June 30     DOI: http://dx.doi.org/10.5045/br.2022.2021137
      
14 Chronic myeloid leukemia: a type of MPN
Muhammad Ammar Samad, Eman Mahboob, Hussain Mansoor
Blood Res.2022;57(2):95-100.   Published online 2022 June 30     DOI: http://dx.doi.org/10.5045/br.2022.2021173
      
15 FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res.2022;57(S1):32-36.   Published online 2022 April 30     DOI: http://dx.doi.org/10.5045/br.2022.2022017
      
16 Human acute myeloid leukemia stem cells: evolution of concept
Dong-Yeop Shin
Blood Res.2022;57(S1):67-74.   Published online 2022 April 30     DOI: http://dx.doi.org/10.5045/br.2022.2021221
      
17 IDH1/2 mutations in acute myeloid leukemia
Ja Min Byun, Seung-Joo Yoo, Hyeong-Joon Kim, Jae-Sook Ahn, Youngil Koh, Jun Ho Jang, Sung-Soo Yoon
Blood Res.2022;57(1):13-19.   Published online 2022 March 31     DOI: http://dx.doi.org/10.5045/br.2021.2021152
      
18 JAK2 V617F 양성 급성골수성백혈병의 임상병리학적 특징 2예
Youngeun Lee, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Sang Mee Hwang
Lab Med Online.2022;12(1):53-57.   Published online 2022 January 1     DOI: http://dx.doi.org/10.47429/lmo.2022.12.1.53
      
19 A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res.2021;56(4):229-242.   Published online 2021 December 31     DOI: http://dx.doi.org/10.5045/br.2021.2021117
      
20 Reduced Osteogenic Differentiation Potential In Vivo in Acute Myeloid Leukaemia Patients Correlates with Decreased BMP4 Expression in Mesenchymal Stromal Cells
Pedro L. Azevedo, Rhayra B. Dias, Liebert P. Nogueira, Simone Maradei, Ricardo Bigni, Jordana S. R. Aragao, Eliana Abdelhay, Renata Binato
Int J Stem Cells.2021;15(2):227-232.   Published online 2021 December 31     DOI: http://dx.doi.org/10.15283/ijsc21138
      

 1 of 10